Trial Profile
Open randomized controlled clinical trial in patients with non-small cell lung cancer, stage IB, II and IIIA, treated or not with VAXIRA, after surgery and adjuvant cisplatin-based chemotherapy
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 19 Oct 2020
Price :
$35
*
At a glance
- Drugs Racotumomab (Primary)
- Indications Carcinoma; Non-small cell lung cancer
- Focus Therapeutic Use
- 26 Aug 2016 New trial record